Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Magnesium Glucoheptonate
Synonyms :
magnesium glucoheptonate
Class :
Magnesium Salt
Dosage Forms & StrengthsÂ
Oral SolutionÂ
100 mg/mlÂ
Administer 15 to 30 mL (1,500 to 3,000 mg) one to three times a day.
It is contraindicated in severe renal impairment.
Dietary recommendations
19 to 30 years:
Females: Administer 310 mg/day
Pregnancy: Administer 350 mg/day
Lactation: Administer 310 mg/day
Males: Administer 400 mg/day
≥31 years:
Females: Administer 320 mg/day
Pregnancy: Administer 360 mg/day
Lactation: Administer 320 mg/day
Males: Administer 420 mg/day
Safety and efficacy not establishedÂ
Refer adult dosingÂ
bismuth subcitrate, metronidazole and tetracycline
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
magnesium salts may decrease the absorption of tetracyclines
may have a decreased serum concentration when combined with phosphate supplements
may have a decreased serum concentration when combined with phosphate supplements
may have a decreased serum concentration when combined with phosphate supplements
tetraferric tricitrate decahydrate
may have a decreased serum concentration when combined with phosphate supplements
may have a decreased serum concentration when combined with phosphate supplements
bismuth subcitrate, metronidazole and tetracycline
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
may have a decreased absorption when combined with tetracyclines
l-methylfolate-pyridoxal 5′-phosphate-methylcobalamine
may reduce the levels of serum concentration of multivitamins
may reduce the level of serum concentration of quinolones
may reduce the level of serum concentration of quinolones
may increase the serum concentration of magnesium salts
may diminish the absorption of Alpha-Lipoic Acid
may diminish the serum concentration when combined
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration of Polyvalent Cation Containing Products
may diminish the absorption when combined with tetracyclines
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids A1
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J3
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the bioavailability of corticosteroids J4
magnesium salts: they may diminish the absorption of phosphate binders
may diminish the serum concentration when combined with vitamin D analogs
it may decrease the levels of serum concentration of Minerals
magnesium Salts may decrease the serum concentration of Dolutegravir
magnesium Salts may decrease the serum concentration of quinolones
magnesium Salts may decrease the serum concentration of quinolones
may diminish the serum concentration of quinolones
may have an increased hypermagnesemic effect when combined with magnesium salts
may have a decreased absorption when combined with alpha-lipoic acid
may increase the serum concentration when combined with magnesium salts
may have a decreased serum concentration when combined with dolutegravir
may have a decreased serum concentration when combined with quinolones
may have a decreased serum concentration when combined with quinolones
bismuth subcitrate, metronidazole and tetracycline
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
may diminish the absorption when combined with tetracyclines
acalabrutinib: they may diminish the serum concentration of magnesium salts
alfacalcidol: they may enhance the serum concentration of magnesium salts
atazanavir: they may diminish the absorption of magnesium salts
cefuroxime: they may diminish the serum concentration of magnesium salts
chloroquine: they may diminish the serum concentration of magnesium salts
dabigatran: they may diminish the serum concentration of magnesium salts
delavirdine: they may diminish the serum concentration of magnesium salts
eltrombopag: they may increase the hypermagnesemic effect of magnesium salts
fosinopril: they may increase the CNS depressant effect of magnesium salts
infigratinib: they may diminish serum concentrations of magnesium salts
mineral oil: they may diminish the serum concentration of Minerals
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration of Polyvalent Cation Containing Products
may decrease the serum concentration when combined
may decrease the serum concentration when combined
may decrease the serum concentration when combined
tetraferric tricitrate decahydrate
may decrease the serum concentration when combined
may decrease the serum concentration when combined
may diminish the serum concentration when combined with raltegravir
may have an increased CNS depressant effect when combined with gabapentin
may have a decreased serum concentration when combined with levothyroxine
may have a decreased serum concentration when combined with fluoride/multivitamins (with ADE)
may decrease the serum concentration of Polyvalent Cation Containing Products
levonorgestrel: they may diminish the serum concentration of magnesium salts
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
may enhance the anticoagulant effect of Vitamin K Antagonists
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the effect of neuromuscular-blocking agents
may reduce the rate of absorption of tetracyclines
may reduce the rate of absorption of tetracyclines
may reduce the rate of absorption of tetracyclines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may decrease the levels of serum concentration of amphetamines
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the antiplatelet effect
may increase the antiplatelet effect
may increase the antiplatelet effect
may increase the antiplatelet effect
may increase the antiplatelet effect
may increases the neuromuscular-blocking effect of Magnesium Salts
may increases the neuromuscular-blocking effect of Magnesium Salts
may increases the neuromuscular-blocking effect of Magnesium Salts
may increases the neuromuscular-blocking effect of Magnesium Salts
may increases the neuromuscular-blocking effect of Magnesium Salts
may decrease the serum concentration of Polyvalent Cation Containing Products
bismuth subcitrate, metronidazole and tetracycline
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may diminish the absorption of magnesium salts
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may increase the arrhythmogenic effect of cardiac glycosides
may increase the arrhythmogenic effect of cardiac glycosides
may increase the arrhythmogenic effect of cardiac glycosides
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
antacids may reduce the serum concentration of minerals
antacids may reduce the serum concentration of minerals
antacids may reduce the serum concentration of minerals
antacids may reduce the serum concentration of minerals
antacids may reduce the serum concentration of minerals
may decrease the serum concentration of minerals
may decrease the serum concentration of minerals
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may reduce the effect of altretamine
may decrease the serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
may decrease the levels of serum concentration
Actions and Spectrum:Â
Frequency not definedÂ
NauseaÂ
VomitingÂ
DiarrheaÂ
Black box warning:Â
NoneÂ
Contraindications/caution:Â
Pregnancy consideration: Prenatal magnesium supplementation may be able to decrease pre-eclampsia and fetal development limitations as well as boost birthweight.Â
Lactation: Excretion of the drug in human breast milk is known.Â
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
<b>Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Pharmacology:Â
Pharmacokinetics:Â
AbsorptionÂ
magnesium glucoheptonate, like other magnesium supplements, is orally administered. After ingestion, it is absorbed through the gastrointestinal tract, mainly in the small intestine. The absorption process may vary depending on factors such as dietary intake, the presence of other substances, and individual variations in gut health.Â
DistributionÂ
Once absorbed, magnesium is distributed throughout the body via the bloodstream. It is an essential mineral that participates in various physiological processes and is involved in the functioning of numerous enzymes and proteins.Â
MetabolismÂ
magnesium glucoheptonate is not metabolized in the body. Instead, it provides a source of elemental magnesium, which the body utilizes for various functions.Â
Elimination and ExcretionÂ
magnesium that is not utilized by the body or stored is excreted primarily through the kidneys in the urine. The excretion rate can be influenced by factors such as kidney function and overall magnesium balance.Â
Administration:Â
Oral administrationÂ
To be taken orally with meals.Â
Patient information leafletÂ
Generic Name: magnesium glucoheptonateÂ
Why do we use magnesium glucoheptonate?Â
magnesium glucoheptonate is expected to address magnesium deficiency and support overall health.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
